International Ovarian Tumour Analysis (IOTA) Phase 5 (IOTA-5)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to learn more about the appearance and behavior of benign-looking adnexal masses.
- Benign-looking means that when viewed here by ultrasound it has the appearance of looking not harmful or not malignant.
- Adnexal refers to the 'adnexa', the space in the female pelvis on either side of the uterus (or where the uterus used to be if you previously had a hysterectomy). The adnexa includes, but is not limited to, the ovaries and the fallopian tubes.
Masses refers to a variety of structures, including but not limited to:
- ovarian cysts that are fluid filled sacs within or attached to an ovary
- ovarian tumors that can be solid tissue or a combination of cysts and solid tissue
- hydrosalpinges that are fluid collections in the fallopian tube
Many women have what appear to be benign adnexal masses. Many times, removal of the masses with surgery is not necessary. Often surgery is performed unnecessarily, for fear that these masses could be cancer. There is not much information available for doctors to know how and when to follow these masses, or which ones will become cancer.
This study will combine information from centers all around the world regarding the behavior of all types of benign adnexal masses. The aim of this study is to develop decision tools for doctors to know the best way to treat these masses in order to improve the detection of ovarian cancer while at the same time reduce the number of unnecessary operations.
| Condition |
|---|
|
Adnexal Masses Ovarian Cysts Ovarian Tumors |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | A Multicentre Study to Examine the Short and Long Term Outcomes of the Conservative Management of Benign-looking Adnexal Masses and the Pre-operative Characterisation of Ovarian Tumours |
- Frequency of complications such as rupture, torsion, or malignancy in patients with benign looking conservatively treated masses [ Time Frame: Up to five years ] [ Designated as safety issue: Yes ]
- Test the published IOTA diagnostic models for predicting that a mass is malignant at first visit or benign [ Time Frame: Up to five years ] [ Designated as safety issue: No ]Also to predict complications (e.g. occurrence of malignancy and other) during long-term follow-up using the diagnostic models
- Investigate factors related to the need for surgery during long-term follow-up [ Time Frame: Up to five years ] [ Designated as safety issue: No ]
- Study natural history of conservatively treated benign-looking adnexal masses [ Time Frame: Up to five years ] [ Designated as safety issue: No ]Also to establish descriptive curves of the longitudinal changes seen in parameters from conservatively managed benign tumors (for example, change in diameter, size of any solid component, number of papillations or color score)
| Estimated Enrollment: | 200 |
| Study Start Date: | September 2012 |
| Estimated Study Completion Date: | September 2018 |
| Estimated Primary Completion Date: | September 2017 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
| benign-looking adnexal masses |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Women being seen at the University of South Florida South Tampa Center
Inclusion Criteria:
- Any woman at least 18 years old with an adnexal mass.
- Any mass with benign ultrasound morphology may be suitable for conservative management.
- Pregnant patients can be included, but their data will be analysed separately.
Exclusion Criteria:
- Cysts that are deemed to be clearly physiological and less than 3 cm in maximum diameter are not eligible for inclusion.
- Any cyst with features of malignancy is excluded from the conservative management
- The denial or withdrawal of oral informed consent
Contacts and Locations| United States, Florida | |
| USF Health South Tampa Center for Advanced Healthcare | |
| Tampa, Florida, United States, 33606 | |
| Principal Investigator: | Lauri Hochberg, MD | University of South Florida |
More Information
No publications provided
| Responsible Party: | University of South Florida |
| ClinicalTrials.gov Identifier: | NCT01698632 History of Changes |
| Other Study ID Numbers: | USF IRB Pro00009001 |
| Study First Received: | September 19, 2012 |
| Last Updated: | September 28, 2012 |
| Health Authority: | United States: Institutional Review Board Belgium: Ethics Committee |
Keywords provided by University of South Florida:
|
Adnexal masses Ovarian cysts Ovarian tumors |
Additional relevant MeSH terms:
|
Ovarian Neoplasms Ovarian Cysts Ovarian Diseases Cysts Endocrine Gland Neoplasms Neoplasms by Site Neoplasms |
Adnexal Diseases Genital Diseases, Female Genital Neoplasms, Female Urogenital Neoplasms Endocrine System Diseases Gonadal Disorders |
ClinicalTrials.gov processed this record on May 23, 2013